Citation Impact
Citing Papers
Should every survivor of a heart attack be given a beta-blocker?
1982
Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction.
1980
Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data
1997 Standout
Anaesthesia, surgery, and challenges in postoperative recovery
2003 Standout
Clinical experience with beta adrenergic blocking agents in myocardial ischaemia: A dilemma and a challenge
1981
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Acute Coronary Care in the Elderly, Part I
2007
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
2003 Standout
Comparison of the Various Electrocardiographic Scoring Codes for Estimating Anatomically Documented Sizes of Single and Multiple Infarcts of the Left Ventricle 11Ulrika S. Pahlm was supported as a Medical Student Research Fellow of the American Heart Association 96/97.
1998
Universal Definition of Myocardial Infarction
2007 Standout
Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery
1996 Standout
Costs and Effectiveness of Routine Therapy with Long-Term Beta-Adrenergic Antagonists after Acute Myocardial Infarction
1988
Coronary microvascular dysfunction in the clinical setting: from mystery to reality
2012
Trends in Management and Outcomes of Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock
2005
Altered thyroid hormone metabolism in advanced heart failure
1990
Omission of Nitrous Oxide during Anesthesia Reduces the Incidence of Postoperative Nausea and Vomiting
1996
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1992 Standout
Preoperative Optimization of Cardiovascular Hemodynamics Improves Outcome in Peripheral Vascular Surgery
1991
Use of doping agents, particularly anabolic steroids, in sports and society
2008 Standout
Bivalirudin during Primary PCI in Acute Myocardial Infarction
2008 Standout
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
2006 Standout
A Factorial Trial of Six Interventions for the Prevention of Postoperative Nausea and Vomiting
2004 Standout
Omitting nitrous oxide in general anaesthesia: meta-analysis of intraoperative awareness and postoperative emesis in randomized controlled trials
1996
Prognosis and Management after a First Myocardial Infarction
1990
Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction
2006 Standout
A Randomized, Controlled Trial of the Use of Pulmonary-Artery Catheters in High-Risk Surgical Patients
2003 Standout
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
2005 Standout
Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles
2007
A Citywide Protocol for Primary PCI in ST-Segment Elevation Myocardial Infarction
2008
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Acute myocardial infarction
2008
Thyroid Hormone and the Cardiovascular System
2001 Standout
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
2003 Standout
Anesthesiology
1997 Standout
β-Blockers and Reduction of Cardiac Events in Noncardiac Surgery
2002
Successes and failures of current treatment of heart failure
1998
Verapamil use in patients with cardiovascular disease: An overview of randomized trials
1998
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
2001 Standout
Antithrombotic Therapy in the Elderly
2010
Guidelines for Percutaneous Coronary Interventions
2005
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
2002 Standout
Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
2009 Standout
The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease
2006
Myocardial Reperfusion Injury
2007 Standout
Transcoronary Transplantation of Progenitor Cells after Myocardial Infarction
2006 Standout
Cardiac Outcome after Peripheral Vascular Surgery
1996
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial
2002 Standout
Preoperative Assessment of Patients with Known or Suspected Coronary Disease
1995
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
1994 Standout
Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction
2004
Coronary-Artery Stents
2006
Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial
2004 Standout
Quantifying heterogeneity in a meta‐analysis
2002 Standout
Cardiomyopathy induced by performance enhancing drugs in a competitive bodybuilder
2005
Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular Disease
1996 Standout
Chronic Kidney Disease
2016 Standout
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration
1994 Standout
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
2003 Standout
Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1
1987
Old antihypertensives and new diabetes
2004
Evaluating the federal role in financing health-related research
1996 StandoutNobel
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial
2011 Standout
Analysis and Interpretation of Treatment Effects in Subgroups of Patients in Randomized Clinical Trials
1991
RANDOMISED PLACEBO-CONTROLLED TRIAL COMPARING OXPRENOLOL WITH DISOPYRAMIDE PHOSPHATE IN IMMEDIATE TREATMENT OF SUSPECTED MYOCARDIAL INFARCTION
1980
Blood pressure, stroke, and coronary heart disease
1990 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data
2000 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Beta blockade during and after myocardial infarction: An overview of the randomized trials
1985 Standout
Limitation of myocardial infarct size in patients less than 66 years treated with alprenolol.
1981
Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction.
1983
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
2000 Standout
EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTION
1981
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
2012 Standout
Treatment with Histamine H2Antagonists in Acute Upper Gastrointestinal Hemorrhage
1985 Standout
A Regional System to Provide Timely Access to Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction
2007
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
A Long-Term Prevention Study with Oxprenolol in Coronary Heart Disease
1982
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Secondary prevention after myocardial infarction: A review of long-term trials
1982
Conducting Meta-Analyses inRwith themetaforPackage
2010 Standout
Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients
2000 Standout
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial.
1982
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
2002 Standout
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
Works of Flemming Pedersen being referenced
The influence of nitrous oxide on recovery of bowel function after abdominal hysterectomy
1993
A Comparison of Coronary Angioplasty with Fibrinolytic Therapy in Acute Myocardial Infarction
2003
Cardiac Event Rates After Acute Myocardial Infarction in Patients Treated With Verapamil and Trandolapril Versus Trandolapril Alone
1997
Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the danish trial in acute myocardial infarction-2 (DANAMI-2)
2003
Effect of intravenous streptokinase on the relation between initial ST-predicted size and final QRS-estimated size of acute myocardial infarcts
1990
Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events
2011
?Low T3-syndrome? in acute myocardial infarction ? Relationship to beta-adrenergic blockade and clinical course
1984
Prediction of cardiac risk in non-cardiac surgery
1987
EFFECT OF ALPRENOLOL ON MORTALITY AMONG PATIENTS WITH DEFINITE OR SUSPECTED ACUTE MYOCARDIAL INFARCTION
1979
III The Effect of Long‐Term Intervention with Alprenolol on Mortality in Definite or Suspected Myocardial Infarction
1984